Florida dermatologist Dr. Leslie Baumann, who was the lead investigator on clinical trials of Dysport, an antiwrinkle treatment that was approved by the FDA last April, has received a warning from that agency for remarks she made to the media about the drug before it was approved. Pharmaceutical companies are not permitted to promote the use of a drug before the FDA approves it (and they are not allowed to promote it for uses other than those approved Read more